Search

Filters

Clear All
  • 49
  • 60
  • 6
  • 3
  • 498

Phase

  • 18
  • 15
  • 3
  • 15
  • 6
  • 15
  • 2
  • 439
  • 582
  • 229
  • 606
  • 10
  • 56
  • 27
  • 1
  • 615

Found 616 results

A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

A Randomized Double-Blind Placebo-Controlled Multi-Center Pragmatic Clinical Trial to Evaluate Effectiveness of Low Dose Oral Methotrexate in Patients with Pediatric Crohn's Disease Initiating Anti-TNF Therapy (COMBINE Umbrella)

All genders
The purpose of this study is to determine whether, in children with Crohn?s disease (CD) initiating anti-TNF (anti-Tumor Necrosis Factor) biological therapy with infliximab or adalimumab, low-dose oral methotrexate (MTX) is more effective than placebo in the induction and subsequent maintenance of steroid-free remission for a treatment period of up …

Designing with People with Stigmatized Conditions

18 years - 100 years
All genders
The purpose of this study is to obtain feedback on designs of social support exchange technology for people living with HIV and their caregivers.

Exploring roles of reflex systems in gait stability and recovery from perturbation

18 years - 100 years
All genders
The purpose of this study is to examine muscular activity of the leg and right lower legs while encountering a perturbation during treadmill walking.

Prospective Randomized Open Label Multi-center Study of the Safety and Pharmacokinetics of Apixaban versus Vitamin K Antagonist or Low Molecular Weight Heparin in Pediatric Subjects with Congenital or Acquired Heart Disease Requiring Chronic Anticoagulation for Thromboembolism Prevention

All genders
The purpose of this study is to find out whether apixaban is safe for children to take, and how much apixaban will be in their blood when they take a certain apixaban dose. We will compare apixaban to other blood thinners commonly used.

HeadStart4: Newly Diagnosed Children (

All genders
This is a prospective randomized clinical trial, to determine whether dose-intensive tandem Consolidation, in a randomized comparison with single cycle Consolidation, provides an event-free survival (EFS) and overall survival (OS).

Executive Functioning and Speech Language Skills in Cochlear Implant Users: The Hearing-Executive Function-Language-Learning Outcomes (HELLO) Project

3 years - 39 years
All genders
We call this new study the HELLO Study. HELLO stands for Hearing, Executive Function, Language and Learning Outcomes. The purpose of this study is to better understand how children with hearing loss develop spoken language skills and executive functioning, such as paying attention, remembering things, and staying focused. The new …

DART: Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors

18 years - 100 years
All genders
This clinical trial studies nivolumab and ipilimumab in treating patients with rare tumors.

Multiple Phase 1 Safety Cohorts of Nivolumab Monotherapy or Nivolumab Combination Regimens Across Relapsed/Refractory Hematologic Malignancies

18 years - 100 years
All genders
The purpose of this study is to test the effectiveness (how well the drug works), safety, and tolerability of an investigational drug called nivolumab (also known as BMS-936558).

Ventilatory Characteristics of Trained Competitive Swimmers During Rest and Exercise

18 years - 40 years
Male
The purpose of this study is to investigate the influence of partial water immersion and body position on the pulmonary mechanics of trained swimmers. We will examine the differences in the amounts of pressure generated by the ventilatory muscles necessary to produce a breath while partially submerged in the water.

A Pilot Study of Rituximab (RTX) and Third Party Latent Membrane Protein (LMP)-Specific Cytotoxic T-Lymphocytes in Pediatric Solid Organ Recipients (SOT) With EBV-Positive CD20-Positive Post-Transplant Lymphoproliferative Disease (PTLD)

All genders
This pilot clinical trial studies how rituximab and latent membrane protein (LMP)-specific T-cells work in treating pediatric solid organ recipients with Epstein-Barr virus-positive, cluster of differentiation (CD)20-positive post-transplant lymphoproliferative disorder.
181 - 190 of 616